Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
93.00
-0.52 (-0.56%)
At close: Mar 9, 2026, 4:00 PM EDT
93.22
+0.22 (0.23%)
After-hours: Mar 9, 2026, 6:08 PM EDT
Rhythm Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -196.54 | -260.6 | -184.68 | -181.12 | -69.61 | |
| Depreciation & Amortization | 1.34 | 1.56 | 1.76 | 1.67 | 1.16 | |
| Loss (Gain) From Sale of Investments | -6.52 | -8.17 | -9.84 | -1.27 | - | |
| Stock-Based Compensation | 66.82 | 39.68 | 32.55 | 19.83 | 20.8 | |
| Other Operating Activities | 20.19 | 103.07 | 19.24 | 4.87 | -100.25 | |
| Change in Accounts Receivable | -7.57 | -3.65 | -8.64 | -5.2 | -1.25 | |
| Change in Inventory | -7.47 | -10.12 | -5.71 | -2.81 | -0.01 | |
| Change in Accounts Payable | 21.89 | 21.92 | 14.77 | 1.54 | 18.31 | |
| Change in Unearned Revenue | -1.09 | - | -0.15 | -6.61 | - | |
| Change in Other Net Operating Assets | -6.72 | 2.42 | 4.53 | -4.34 | -15.15 | |
| Operating Cash Flow | -115.68 | -113.88 | -136.16 | -173.43 | -146 | |
| Capital Expenditures | -0.95 | - | -0.05 | -0.28 | -0.43 | |
| Sale (Purchase) of Intangibles | -40 | -40.5 | -5.67 | - | 7 | |
| Investment in Securities | -96.2 | -7.67 | 0.05 | 32.31 | -163.73 | |
| Other Investing Activities | - | - | - | -4 | 95 | |
| Investing Cash Flow | -137.15 | -48.17 | -5.67 | 28.03 | -62.16 | |
| Issuance of Common Stock | 237.88 | 56.39 | 57.4 | 141.49 | 166.48 | |
| Other Financing Activities | -19.92 | -4 | 16.97 | 72.34 | - | |
| Financing Cash Flow | 217.96 | 191.24 | 74.37 | 213.83 | 166.48 | |
| Foreign Exchange Rate Adjustments | 0.09 | 0 | -0.14 | - | - | |
| Net Cash Flow | -34.78 | 29.19 | -67.6 | 68.43 | -41.68 | |
| Free Cash Flow | -116.63 | -113.88 | -136.2 | -173.71 | -146.44 | |
| Free Cash Flow Margin | -61.46% | -87.51% | -175.91% | -734.87% | -4642.90% | |
| Free Cash Flow Per Share | -1.79 | -1.87 | -2.36 | -3.33 | -2.95 | |
| Levered Free Cash Flow | -145.98 | -81.99 | -91.47 | -105.11 | -57.05 | |
| Unlevered Free Cash Flow | -133.12 | -69.11 | -82.79 | -101.86 | -57.05 | |
| Change in Working Capital | -0.97 | 10.58 | 4.81 | -17.41 | 1.9 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.